✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Pain ManagementSynthetic CannabinoidsDrug DevelopmentAdverse EffectsResearch Why This MattersNovel synthetic cannabinoid molecules represent a potential...
Putting Patients First in Drug Development | Applied Clinical Trials Online
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Clinical ResearchPatient-Centered CareReal-World EvidenceDrug DevelopmentPatient-Reported Outcomes Why This MattersPatient-centered drug development approaches are...
CBC–RIS partnership signals AI-led transformation for healthcare and pharma: Experts
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Artificial IntelligenceClinical Decision SupportDrug DevelopmentHealthcare TechnologyResearch Methods Why This MattersAI partnerships in healthcare and...
Two compounds found in cannabis plant reverse liver disease damage, study suggests
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic HepatologyPreclinical ResearchAnti-InflammatoryFibrosisDrug Development Why This MattersLiver disease represents a significant morbidity burden where...
Forge Genetics announces licensing deal to explore Forge Editing in pharmaceutical uses
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic BiotechnologyDrug DevelopmentGene EditingPharmaceuticalsInnovation Why This MattersGene editing technologies like CRISPR are increasingly being explored...
Avicanna Announces Changes to its Board of Directors – FirstWord Pharma
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PharmaceuticalsClinical ResearchIndustryDrug DevelopmentCorporate Why This MattersBoard changes at cannabis pharmaceutical companies can signal strategic...
Expanded use of CBD in medical research gets FDA approval – KTALnews.com
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdFda RegulationClinical ResearchEvidence-Based MedicineDrug Development Why This MattersFDA approval for expanded CBD research protocols...
CBD Shows Promise But Lacks Broad Regulatory Approval: A Sobering Review of the Evidence
The global appeal of therapeutic uses of CBD is growing more rapidly than the scientific evidence supporting its safety and effectiveness.
Large Genetic Meta-Analysis Finds Endocannabinoid Pathway Variants Linked to Shared Psychiatric Risk
We identified nine SNPs significantly associated with a change in risk of having a mental disorder. The lead SNP was rs12805732 (Gene: Diacylglycerol Lipase Alpha; DAGLA). Four SNPs had substantial heterogeneity (I²>60%). DAGLA had the strongest association with disease risk in gene-based analysis.
MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Synthetic CannabinoidsCns Side EffectsDrug DevelopmentCb1 AntagonistsPharmaceutical Research Why This MattersEarly preclinical data suggests MIRA-55,...